Literature DB >> 3340456

Sepsis in febrile neutropenic children with cancer.

J Langley1, R Gold.   

Abstract

Infection is the leading cause of death in children with cancer. A retrospective review of 100 episodes of sepsis in 80 children with cancer for a 21-month period showed that 74% of isolates were Gram-positive bacteria. Coagulase-negative staphylococci were the most common pathogens, accounting for 35% of all isolates. Initial empiric antibiotic therapy of fever in neutrogenic cancer patients was piperacillin and tobramycin. All but 12% of the Gram-negative isolates were susceptible to one or both of the antibiotics. However, 31% of the Gram-positive isolates were resistant to both antibiotics and 38% of the coagulase-negative staphylococci were methicillin-resistant. All of the latter were susceptible to vancomycin. The increasing incidence of coagulase-negative staphylococci as causes of sepsis in cancer patients suggests that the choice of antibiotics for initial empiric therapy may need to include vancomycin or an antistaphylococcal penicillin depending on the local incidence of methicillin resistance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3340456     DOI: 10.1097/00006454-198801000-00008

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Defining Staphylococcus epidermidis cell wall proteins.

Authors:  C C Patrick; M R Plaunt; S M Sweet; G S Patrick
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

2.  Antimicrobial susceptibility of viridans group streptococci isolated from patients with acute leukemia receiving ofloxacin for antibacterial prophylaxis.

Authors:  W Kern; K Linzmeier; E Kurrle
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

3.  Cost analysis of 2 empiric antibacterial regimens containing glycopeptides for the treatment of febrile neutropenia in patients with acute leukaemia.

Authors:  G Bucaneve; F Menichetti; A Del Favero
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

4.  Role of the Staphylococcus epidermidis slime layer in experimental tunnel tract infections.

Authors:  C C Patrick; M R Plaunt; S V Hetherington; S M May
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

5.  A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.

Authors:  W V Kern; B Hay; P Kern; R Marre; R Arnold
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

6.  Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.

Authors:  W Kern; E Kurrle; T Schmeiser
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

7.  Factors associated with increased risk in inappropriate empiric antibiotic treatment of childhood bacteraemia.

Authors:  S Ashkenazi; Z Samra; H Konisberger; M M Drucker; L Leibovici
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

8.  The effect of selective decontamination of the digestive tract on gastrointestinal enterococcal colonization in ITU patients.

Authors:  H Humphreys; R Winter; A Pick
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

9.  Changing causes of septicaemia in paediatric oncology patients: effect of imipenem use.

Authors:  J W Gray; S J Pedler; A W Craft; J Kernahan; K P Windebank; A D Pearson
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

10.  Role of neutrophil receptors in opsonophagocytosis of coagulase-negative staphylococci.

Authors:  G E Schutze; M A Hall; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.